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ORIGINAL INVESTIGATION
Determination of Factors Affecting Mortality of Patients 
with Sepsis in a Tertiary Intensive Care Unit 
OBJECTIVES: Sepsis is a disease with high mortality that is frequently observed in intensive care units. This study aimed to determine the 
risk factors affecting mortality of patients with sepsis who were followed up in the intensive care unit (ICU). We aimed to contribute to 
literature by evaluating the relationship between mortality and pro-brain natriuretic peptide (pro-BNP9), C-reactive protein (CRP), throm-
bocyte count, Acute Physiology and Chronic Health Evaluation (APACHE) II score, Sequential Organ Failure Assessment (SOFA) score, 
duration of hospitalization in the intensive care unit, and the presence of multidrug-resistant microorganism.
MATERIAL AND METHODS: Patients hospitalized in ICU because of the diagnosis of sepsis and septic shock between December 2010 
and June 2012 were included in this retrospective study.
RESULTS: A total of 141 patients, including 74 male (52.5%) and 67 female (47.5%) patients, were involved in the study, and the median 
age was 66.8±17.9 years. Sixty-nine patients (48.9%) were discharged from the ICU; however, 72 patients (51.1%) were exitus. Multi-
drug-resistant microorganism was detected in 34 patients (24.1%). The patients’ median SOFA score was 9.16±3.16, median APACHE-II 
score was 24.9±7.83, and median duration of hospitalization in the ICU was 8.44±11.61 days. It was found that mortality rate significant-
ly increased in patients with the APACHE-II score of 24.5 and over, SOFA score of 8.5 and over, pro BNP value of 7241 ng/L and over, and 
CRP value of 96.5 mg/dL and over. Mortality rate was detected to be higher in patients undergoing invasive mechanical ventilation than 
in patients undergoing non-invasive mechanical ventilation. When thrombocyte count and mortality were associated with each other, it 
was found that the median value was 86000 mg/dL in exitus patients, whereas it was 185000 mg/dL in patients discharged from the ICU.
CONCLUSION: It was revealed that increased APACHE-II score, increased SOFA score, increased pro BNP score, increased CRP, the 
presence of multidrug-resistant microorganism, and decreased thrombocyte count elevated the rate of mortality. However, no relation-
ship was observed between the duration of hospitalization in the ICU and mortality. 
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INTRODUCTION
The rate of mortality is quite high in patients monitored in the intensive care unit (ICU) because of sepsis. In patients with 
sepsis, blood circulation is not adequately provided, tissue perfusion is impaired, and organ damage occurs. Shock status 
and organ failure that develop in this situation are the main cause of mortality [1]. Understanding the clinical severity of 
a patient admitted to the ICU immediately and initiating appropriate treatment as soon as possible are the most significant 
efforts that can be performed for decreasing the mortality rate. Serum pro-brain natriuretic peptide (pro-BNP) is a hor-
mone, the level of which demonstrates an increase that depends on sepsis [2]. In addition, serum C-reactive protein (CRP) 
is another biomarker that increases in any case of inflammation, including septicity [3]. To determine mortality rate in 
intensive care patients, there are some scoring methods included in literature [such as Sequential Organ Failure 
Assessment Score (SOFA) and Acute Physiological and Chronic Health Evaluation II (APACHE II) score] [3,4]. In our study, 
the SOFA and APACHE-II scores of patients were evaluated for establishing a relationship with these scores and mortal-
ity. Moreover, the development of thrombocytopenia in patients, presence of multidrug-resistant microorganism [being 
resistant to one or more antibiotics group (beta-lactam, carbapenem, fluoroquinolone, and aminoglycoside], duration of 
hospitalization in the ICU, and administration method of mechanical ventilation [non-invasive mechanical ventilation 
(NIMV)/invasive mechanical ventilation (IMV)] were examined. This study aimed to demonstrate the prognostic value of 
biomarkers in patients with sepsis, to associate clinical scoring methods used in intensive care patients to clinical sever-
ity of patients, and to determine the mortality rate of patients. In addition, it was aimed to contribute to literature by 
identifying a limit value considering the numerical results 
that we obtained and to show the value above which the 
mortality rate increased.
MATERIAL AND METHODS
The study included patients with sepsis and septic shock 
hospitalized in the ICU between December 2010 and June 
2012. Of the 412 patients monitored between these dates, 
168 patients had sepsis and septic shock among 298 patients 
whose recordings were reached.
The worst result of laboratory examinations performed in the 
first 24 h was evaluated. To avoid a misleading value of pro-
BNP, which is a hormone that increases in blood in cases of 
heart failure and renal failure, the patients who had pro-PNO 
value before the application of fluid resuscitation and who 
were not diagnosed with chronic heart failure (CHF) and 
chronic renal failure (CRF) were involved in the study. In 
contrast, patients with any inflammatory disease that could 
lead to elevated serum CRP value (such as lupus and rheu-
matoid arthritis) were excluded from the study. Patients with 
the development of isolated infection and followed by sepsis 
were included in the study. 
The study was conducted after receiving the approval of the 
Ethics Committee of Marmara University Medical Faculty.
Statistical Analysis
The data obtained were statistically analyzed using Statistical 
Package for Social Sciences (SPSS Inc., Chicago IL, USA) 19 
software for Windows XP. The p value below 0.05 was 
accepted to be significant. The factors thought to have affect-
ed mortality were statistically evaluated with Pearson chi-
square test and Fisher’s exact test, and the data obtained were 
presented as median. For some data (pro-BNP, CRP, APACHE 
II score, and SOFA score), ROC curve was used for finding a 
threshold value. With this technique, it was aimed to demon-
strate the specificity and sensitivity of mortality increase in 
patients having a result above a certain threshold value. 
RESULTS
Twenty-seven of the 168 patients in the study were excluded 
because they had the diagnoses of CHF and CRF, and a total 
of 141 patients were evaluated. Demographic features of the 
patients are presented in Table 1. 
Of 141 patients, 74 (52,5%) were males and the median age 
was 66.8±17.9 years. While 69 patients (48.9%) were dis-
charged from the intensive care unit, 72 patients (51.1%) 
were exitus. The number of patients in which multidrug-
induced microorganism growth developed in the ICU was 34 
(24.1%). It was observed that the number of gram negative (-) 
microorganisms (Acinetobacter baumannii, Pseudomonas 
aeruginosa, Escherichia coli, and Klebsiella pneumoniae) 
was higher among other factors. In addition, vancomycin-
resistant enterococcus and persistent candida infection were 
also detected. SOFA scores of patients ranged from 4 to 16, 
and the median value was found to be 9.16 (±3.16). Their 
APACHE-II scores varied between 11 and 36, and the median 
value was 24.9 (±7.83). Moreover, the duration of hospital-
ization in the ICU was found to be between 1 and 124 days, 
and the median value was 8.44 (±11.61) days. While 
mechanical ventilation procedure was applied to 126 
patients (89.4%) during their hospitalization in the ICU, it 
was not applied to 15 patients (10.6%). Of the 126 mechan-
ical ventilation supports, 70 (55.6%) were IMV and 56 
(44.4%) were NIMV. When mechanical ventilation was asso-
ciated to mortality, it was observed that 11 (19.6%) of the 56 
patients having undergone NIMV were exitus and 45 
(80.4%) were discharged from the ICU. In contrast, it was 
detected that only 10 (14.3%) of 70 patients having under-
gone IMV were discharged and 60 (86.7%) were exitus. It 
was concluded that the mortality rate was 8.44 times higher 
in patients having undergone IMV than in patients having 
undergone NIMV (Table 2). 
The relationship between APACHE-II scores, SOFA scores, 
low thrombocyte count, CRP values, and pro-BNP values of 
patients and mortality were investigated and threshold values 
were calculated for these values (Figure 1). 
In the calculations, it was found that mortality rate signifi-
cantly increased in patients with SOFA score of 8.5 and above 
(90% sensitivity and 80% specificity). While mortality 
increased in patients with APACHE-II score of 24.5 and over 
at a significant level, CRP and pro-BNP scores were not found 
to be as valuable as APACHE-II and SOFA scores despite their 
guiding sensitivity and specificity for mortality. In patients 
having pro-BNP value of 7241 pg/mL and more, mortality rate 
increased with 70% sensitivity and specificity. In contrast, in 
patients with CRP value of 96.5 mg/L and more, mortality 
increased with 65% sensitivity and specificity. 
In the evaluation of the relationship between mortality and 
thrombocytopenia, it was revealed that the median thrombo-
cyte count was lower in exitus patients (86000 mg/dL) and 
this value was 185000 mg/dL in patients discharged from the 
ICU. A significant relationship was demonstrated between 
thrombocyte count and mortality in patients with sepsis and 
septic shock (p<0.05). 
DISCUSSION
In this study, the factors affecting mortality in patients with 
sepsis hospitalized in a tertiary intensive care unit were 
investigated. A direct relationship was found between mor-
tality and APACHE-II score, SOFA score, pro-BNP and CRP 
increase, and IMV application. 129
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Table 1. Demographic features of patients included in the 
study 
 n (%)
Female 67 47.5
Male 72 52.5
Malignancy 43 30
Chronic obstructive pulmonary disease (COPD) 38 26
Pneumonia 34 24
Urinary tract infection 14 0.9
Asthma  7 0.4
Others 5 0.03
 In our study, the median pro-BNP value was found to be 3726 
pg/mL in patients discharged from the ICU, and it was 
observed that mortality significantly increased in patients with 
pro-BNP value above 7241 pg/mL. In literature review, in the 
study conducted by Rudriger et al. [5], the median pro-BNP 
value was detected to be 6526 pg/mL, and pro-BNP increased 
in patients with sepsis and septic shock. In another prospective 
study, patients monitored in the ICU because of sepsis and 
septic shock were evaluated, and the median pro-BNP value 
was found to be 7386 pg/mL in patients discharged from ICU 
and 13415 pg/mL in exitus patients. Therefore, it was reported 
that pro-BNP value increased in sepsis, and it was directly 
associated with mortality [6]. In a retrospective study evaluat-
ing 254 patients with sepsis and septic shock in 24 ICU in 
Finland, it was reported that the median pro-BNP value was 
3479 pg/mL in discharged patients and 7908 pg/mL in exitus 
patients, and pro-BNP value increased in sepsis and septic 
shock and was related to mortality [2].
In our results, it was revealed that CRP value increased in 
sepsis and septic shock patients and an increase in the serum 
concentration was directly correlated with mortality. It was 
also found that prognosis was poorer in the patients with 
CRP value of 96.5 mg/L and over. Similar results have also 
been reported in literature. In a study in which 204 patients 
with sepsis hospitalized in the ICU were examined, median 
CRP value was found to be 148 mg/L, and it was stated that 
CRP value increased in sepsis [7]. In a similar study, 
increased CRP value was found to be directly associated with 
mortality, and it was revealed that mortality rate increased in 
patients whose CRP value was 128 mg/L and over [8]. Kepa 
et al. [9] performed a prospective study and evaluated 30 
patients hospitalized in the ICU for bacterial sepsis. They 
reported that CRP level increased in bacterial sepsis and this 
increase was associated with clinical severity. The results of 
our study are consistent with literature. The mortality rate 
increases in parallel with elevated CRP value. While the cut-
off value of mortality was found to be 128 mg/L in the study 
of Castelli et al. [8], this value was lower in our study and 
patient mortality significantly increased at the value of 98.5 
mg/L and over. 
In our study, it was demonstrated that mortality increased 
with elevated SOFA score, and mortality rate was signifi-
cantly high in patients with SOFA score of 8.5 and over. In a 
meta-analysis evaluating 1449 intensive care patients in a 
community, patients were followed up for 5 days, and an 
increase of 44% was observed in SOFA scores of exitus 
patients and a decrease of 33% was found in SOFA scores of 
discharged patients. They concluded that decreased SOFA 
score indicated decreased mortality and increased SOFA 
score indicated increased mortality [10]. In another study in 
which 352 intensive care patients were prospectively evalu-
ated, it was detected that mortality increased at a significant 
level in patients with the SOFA score of 11 and over, and 
mortality was also high in patients whose SOFA score 
increased by 50% and above in the follow-ups [11]. There 
are many studies evaluating the relationship between SOFA 
score and patient mortality in literature. In all of these stud-
ies, it was reported that mortality rate increased as SOFA 
scores of patients increased as in our study. 
Another scoring system, APACHE-II score is the most com-
prehensive scoring system performed by evaluating many 
parameters in patients hospitalized in the ICU. In our study, it 
was observed that mortality increased in parallel with elevat-
ed APACHE-II scores. It was detected that mortality rate was 
higher in patients whose APACHE-II score was 24.5 and over. 
In the same way, in a study evaluating 366 intensive care 
patients, it was reported that patient mortality rate increased 
as the APACHE-II scores of patients increased and mortality 
was significantly high in patients with APACHE-II score of 24 
and over (p<0.05).
In a retrospective study of Fadaizadeh et al. [12] conducted 
with 415 patients, it was specified that there was a direct 
relationship between increased APACHE-II score and mortal-
ity, and mortality rate increased in patients whose APACHE-II 
scores were 27 and over. Del Buffalo et al. [4] evaluated 
SAPS and APACHE-II scores of patients hospitalized in the 
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Table 2. Factors affecting survival in patients 
Parameters Dead  Alive p
Age (year) 69 (±17.9) 69.5 (±14.9) >0.05
APACHE II 29.5 (±7.8) 19 (±5.2) <0.001
SOFA 11.5 (±5.2) 7 (±2.7) <0.001
IMV 60 (86.7%) 10 (14.3%) <0.001
NIMV 11 (19.6%) 45 (80.4%) <0.001
Pro BNP (pg/mL) 10428 3726 <0.05
CRP (mg/dL) 144 74 <0.05
Thrombocyte (number/mL) 76000 186000 <0.05
Duration of hospitalization (day) 9 (±11.6) 7 (±7.8) >0.05
APACHE II: Acute Physiology and Chronic Health Evaluation II score; 
SOFA: Sequential Organ Failure Assessment; IMV: invasive mechanical 
ventilation; NIMV: non-invasive mechanical ventilation; pro-BNP brain 
natriuretic peptide; CRP: C-reactive protein
Figure 1. Calculated threshold values for APACHE II score, SOFA 
score, thrombocyte count, CRP value and pro-BNP value
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ICU in their study, and they suggested that APACHE-II score 
was superior to SAPS score with regard to the determination 
of mortality rate. In another study, it was stated that mortality 
rate was higher in patients whose APACHE-II scores were 25 
and above [13]. In literature review, it has been observed that 
there is a strong relationship between APACHE-II score and 
mortality as in our study. 
According to our results, the presence of multidrug-resistant 
microorganism was found in 34 patients during their hospi-
talization in the ICU. Of these patients, 24 (70.6%) died and 
10 (29.4%) were discharged from the ICU. A statistically 
significant relationship was detected between the presence 
of multidrug-resistant microorganism and mortality (p<0.01). 
Fagon et al. [14] conducted a study and evaluated 567 inten-
sive care patients intubated for >3 days, and they concluded 
that the possibility for microbiological reproduction and the 
development of multidrug-resistant microorganisms and 
mortality rate increased with prolonged intubation time. In 
the study of Craven et al. [15] performed with 233 patients, 
they observed the development of persistent infection in 
21% of patients, and they calculated the mortality rate as 
55% in patients with persistent infection. In literature, the 
microorganism that mostly leads to mortality in intensive 
care patients is A. baumannii as shown in our study 
[14,16,17]. It is observed that the mortality rate of intensive 
care patients is approximately 50% in the presence of multi-
drug-resistant microorganisms. 
When the requirement for mechanical ventilation by patients 
were evaluated, it was found that mortality in patients receiv-
ing IMV was higher than in patients who were applied NIMV. 
Carlucci et al. [16] examined 689 patients in their study, and 
IMV and NIMV were administered to 581 and 108 patients, 
respectively. According to their results, multidrug-resistant 
microorganism grew in IMV patient group and mortality was 
seven times higher compared with NIMV group. In the study 
of Antonelli et al. [18] conducted with 35 patients, mortality 
rate was detected to be 47% in the IMV group and 28% in 
the NIMV group (p=0.19). This result was not statistically 
significant because of the low number of patients. However, 
as is observed, mortality was higher in the IMV group. In our 
study and in similar studies in literature, mortality of patients 
provided IMV support is higher than that of patients provided 
NIMV support. Patients provided NIMV support have a more 
stable clinic compared with patients undergoing IMV; there-
fore, better course of NIMV group is an expected result. In 
addition, some problems associated with intubation nega-
tively affects IMV patients. For example, there is a direct 
connection between the lungs of these patients and outer 
environment, and this situation allows for opportunistic 
infections. Moreover, secretions in the oropharyngeal region 
go down the lungs as a negative outcome of intubation, 
resulting in hospital-acquired infections. 
In the evaluation of the relationship between mortality and 
thrombocytopenia, it was found that the median thrombo-
cyte count was lower in exitus patients compared with dis-
charged patients. Aydemir et al. [19] examined 214 patients 
with sepsis in their retrospective study and revealed that 
patient mortality increased with the development of throm-
bocytopenia (p<0.05). In another study in which 329 
patients diagnosed with sepsis were evaluated, it was 
detected that patients whose thrombocyte count was 
150000 and below or whose thrombocyte count decreased 
by >50% demonstrated a more mortal course [20]. 
The main limitation of our study is that planned number of 
patients could not be reached through the files obtained 
from the archive because archiving of patient files is manu-
ally performed instead of on computer in our country. 
Therefore, it will be more appropriate to plan a similar fur-
ther study as prospective rather than retrospective. 
In this study, the factors affecting mortality in patients with 
sepsis and septic shock hospitalized in ICU were assessed. 
While no relationship was found between mortality and 
patients’ ages and the duration of hospitalization in ICU, 
there was a strong relationship between mortality and ele-
vated pro-BNP and CRP values, low thrombocyte count, 
and increased SOFA and APACHE-II scores.
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